Trial Profile
Comparison of the tolerability and immunogenicity of a meningococcal serogroup B vaccine [MenB] and a meningococcal groups B and C vaccine [VA-Mengoc-BC] in young adult volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jan 2011
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine groups B and C (Primary) ; Meningococcal vaccine group B
- Indications Meningococcal infections
- Focus Adverse reactions; Pharmacodynamics
- 17 Jan 2011 New trial record